MAMS4CL 1 840x320

AHRI hosts international experts for a new clinical trial to assess treatments for cutaneous leishmaniasis

Armauer Hansen Research Institute(AHRI) hosted a productive consultative and kickoff of workshop for a new research project, MAMS4CL: A Multi-Arm, Multi-Stage Clinical Trial for Cutaneous Leishmaniasis, funded by Global Health EDCTP3. The workshop was held 15-1 7October, 2025 in Bishoftu, Ethiopia.